The Lung Cancer Channel is supported with funding from Johnson & Johnson (Gold) and Takeda (Gold).
VJOncology is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
ELCC 2017 | Evolving guidelines for molecular testing in lung cancer
Fred Hirsch, MD, PhD from the University of Colorado, Denver, CO speaks about the collaboration between IASLC, CAP and AMP to develop guidelines for molecular testing in lung cancer. The field of molecular testing is rapidly evolving and therefore guidelines need to be developed and updated continuously. This interview was recorded at the annual meeting of the European Lung Cancer Conference (ELCC) 2017, Geneva, Switzerland.
